Synthetic Biology
«Synthetic Biology - a multidisciplinary area engaged in creating new biological parts, devices, systems, and DNA based therapeutics. ArcticZymes ligases (prototypes) and polymerases show great promise for future utility in this market.»
MarketsandMarkets™ Strategic Insights:
Synthetic Biology Market worth $30.7 billion by 2026
USD 9.5 billion in 2021
Liquid Biopsies
«Liquid Biopsies – DNA or other diagnostics tests are performed on blood or other body fluids. Unlike traditional invasive biopsies, liquid biopsies require a whole new set of molecular techniques to overcome the challenges of isolating very small amounts of DNA and amplifying it sufficiently to allow diagnosis. ArcticZymes´ proteinase, DNases, and SAN enzymes are already supporting customer efforts in developing such technologies»
Alliedmarketresearch:
The global liquid biopsy market size accounted for $1,204.2 million in 2020, and is estimated to reach $6,804.9 million by 2028, registering a CAGR of 20.9% from 2021 to 2028.
«Therapeutics – Gene Therapy
ArcticZymes´ business towards serving manufacturers of viral-based gene therapies and vaccines is a relatively new business. All our customers are still in the early stages of their development programs»
Fortune Business Insights:
The report further mentions that the market size was USD 3.61 billion in 2019 and is projected to reach USD 35.67 billion by 2027, exhibiting a CAGR of 33.6% during the forecast period”